A significant advance in cancer research is arising with the use of mini-antibodies to restore mutated p53. This vital malignant inhibitor protein is frequently inactivated in several forms of malignancies, resulting https://companyspage.com/story6974213/nanobodies-reactivate-p53-the-promising-pathway-for-tumor-therapy